Prellis Biologics Raises $35M in Series C Funding
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
📰 Prellis Bio News
Prellis Bio News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Prellis Bio. Real-time updates on events, politics, business and more.
Prellis Biologics Appoints New CEO, Raises $35 Million in Series C Funding to Leverage Human Immune
Former Generate Biomedicines, Amgen and Novartis senior leader Mike Nohaile joins Prellis as CEOSAN FRANCISCO--(BUSINESS WIRE)--Prellis Biologics, Inc (Prellis Bio), a biotherapeutics company, today appointed Michael Nohaile, PhD as its new CEO and announced it has raised a $35 million Series C funding round, co-led...
Source: pharmiweb.com
Prellis Biologics raises $14.5M, debuts a "human immune system" in a dish – TechCrunch
Prellis Biologics, a company developing the tools to create 3D printed organs, announced a $14.5 million Series B round on Wednesday. Prellis has spent years developing tissue engineering capacity, but has focused recently on developing one type of structure in particular. Up until this point, Prellis has focused on 3D printing vascular scaffolds that would […]
Source: techcrunch.com